Who Paid My Doc
Penbraya
Biological Vaccines
NDC 0069-0600-01
General payments
$931,627
Research payments
$352,772
Through program year 2025, $931,627 in general payments and $352,772 in research payments were reported against Penbraya (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $330,502 | 11,411 |
| 2025 | Research | $156,019 | 18 |
| 2024 | General | $542,677 | 15,204 |
| 2024 | Research | $157,332 | 2 |
| 2023 | General | $58,449 | 350 |
| 2023 | Research | $39,421 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 89 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
26,965 general · 21 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.